EE03381B1 - Pulbrilised ravimvormid, mis sisaldavad lahjendajana melesitoosi - Google Patents

Pulbrilised ravimvormid, mis sisaldavad lahjendajana melesitoosi

Info

Publication number: EE03381B1
Authority: EE; Estonia
Prior art keywords: diluent; formulations containing; powder formulations; containing melezitose; melezitose
Prior art date: 1994-12-22

Application number

EE9700135A

Other languages

English (en)

Estonian (et)

Other versions

EE9700135A (et

Inventor

B�ckstr�m Kjell

Johansson Ann

Linden Helena

Original Assignee

Astra Aktiebolag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-22

Filing date

1995-12-19

Publication date

2001-04-16

1995-12-19 Application filed by Astra Aktiebolag filed Critical Astra Aktiebolag

1997-12-15 Publication of EE9700135A publication Critical patent/EE9700135A/xx

2001-04-16 Publication of EE03381B1 publication Critical patent/EE03381B1/xx

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pulmonology (AREA)
Diabetes (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Otolaryngology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Zoology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biochemistry (AREA)
Molecular Biology (AREA)
Oil, Petroleum & Natural Gas (AREA)
Toxicology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Peptides Or Proteins (AREA)

EE9700135A 1994-12-22 1995-12-19 Pulbrilised ravimvormid, mis sisaldavad lahjendajana melesitoosi EE03381B1 (et)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
SE9404468A SE9404468D0 (sv)	1994-12-22	1994-12-22	Powder formulations
PCT/SE1995/001541 WO1996019207A1 (en)	1994-12-22	1995-12-19	Powder formulations containing melezitose as a diluent

Publications (2)

Publication Number	Publication Date
EE9700135A EE9700135A (et)	1997-12-15
EE03381B1 true EE03381B1 (et)	2001-04-16

Family

ID=20396435

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EE9700135A EE03381B1 (et)	1994-12-22	1995-12-19	Pulbrilised ravimvormid, mis sisaldavad lahjendajana melesitoosi

Country Status (33)

Country	Link
US (1)	US6004574A (xx)
EP (2)	EP1224929B1 (xx)
JP (1)	JPH10510828A (xx)
KR (1)	KR100391873B1 (xx)
CN (1)	CN1080114C (xx)
AR (1)	AR002261A1 (xx)
AT (2)	ATE220900T1 (xx)
AU (1)	AU702898B2 (xx)
BR (1)	BR9510422A (xx)
CA (1)	CA2206803A1 (xx)
CZ (1)	CZ288487B6 (xx)
DE (2)	DE69527542T2 (xx)
DK (2)	DK0799030T3 (xx)
EE (1)	EE03381B1 (xx)
ES (2)	ES2222306T3 (xx)
FI (1)	FI972654A7 (xx)
HU (1)	HU217975B (xx)
IL (1)	IL116459A (xx)
IS (1)	IS1848B (xx)
MY (1)	MY114211A (xx)
NO (1)	NO315966B1 (xx)
NZ (1)	NZ298168A (xx)
PL (1)	PL183944B1 (xx)
PT (2)	PT1224929E (xx)
RU (1)	RU2144819C1 (xx)
SA (1)	SA95160484B1 (xx)
SE (1)	SE9404468D0 (xx)
SK (1)	SK283147B6 (xx)
TR (1)	TR199501632A1 (xx)
TW (1)	TW474823B (xx)
UA (1)	UA44757C2 (xx)
WO (1)	WO1996019207A1 (xx)
ZA (1)	ZA9510753B (xx)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5830853A (en)	1994-06-23	1998-11-03	Astra Aktiebolag	Systemic administration of a therapeutic preparation
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
US6632456B1 (en) *	1993-06-24	2003-10-14	Astrazeneca Ab	Compositions for inhalation
US6794357B1 (en)	1993-06-24	2004-09-21	Astrazeneca Ab	Compositions for inhalation
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US6932962B1 (en)	1994-12-22	2005-08-23	Astrazeneca Ab	Aerosol drug formulations containing hydrofluoroalkanes and alkyl saccharides
DE69806362T2 (de) *	1997-03-20	2003-01-30	Novo Nordisk A/S, Bagsvaerd	Therapeutische pulverformulierung zur pulmonaren anwendung, welche kristallines insulin enthält
US6043214A (en) *	1997-03-20	2000-03-28	Novo Nordisk A/S	Method for producing powder formulation comprising an insulin
US5898028A (en) *	1997-03-20	1999-04-27	Novo Nordisk A/S	Method for producing powder formulation comprising an insulin
WO2000061178A1 (en) *	1999-04-13	2000-10-19	Inhale Therapeutics Systems, Inc.	Pulmonary administration of dry powder formulations for treating infertility
AU779869B2 (en) *	1999-04-13	2005-02-17	Nektar Therapeutics	Pulmonary administration of dry powder formulations for treating infertility
US7169889B1 (en)	1999-06-19	2007-01-30	Biocon Limited	Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
GB0011807D0 (en) *	2000-05-16	2000-07-05	Quadrant Holdings Cambridge	Formulation for inhalation
AU2001281113B2 (en)	2000-08-07	2006-07-20	Nektar Therapeutics	Inhaleable spray dried 4-helix bundle protein powders having minimized aggregation
US7060675B2 (en)	2001-02-15	2006-06-13	Nobex Corporation	Methods of treating diabetes mellitus
US6867183B2 (en)	2001-02-15	2005-03-15	Nobex Corporation	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6713452B2 (en)	2001-06-04	2004-03-30	Nobex Corporation	Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828305B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en)	2001-06-04	2004-12-07	Nobex Corporation	Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6835802B2 (en)	2001-06-04	2004-12-28	Nobex Corporation	Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US7713932B2 (en)	2001-06-04	2010-05-11	Biocon Limited	Calcitonin drug-oligomer conjugates, and uses thereof
US6858580B2 (en)	2001-06-04	2005-02-22	Nobex Corporation	Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7030082B2 (en) *	2001-09-07	2006-04-18	Nobex Corporation	Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith
US6770625B2 (en)	2001-09-07	2004-08-03	Nobex Corporation	Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith
US6913903B2 (en)	2001-09-07	2005-07-05	Nobex Corporation	Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en)	2001-09-07	2007-01-23	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en)	2001-09-07	2007-03-27	Biocon Limited	Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7312192B2 (en)	2001-09-07	2007-12-25	Biocon Limited	Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
CN1607941A (zh)	2001-11-19	2005-04-20	贝克顿迪肯森公司	粒状药物组合物
SE0200657D0 (sv) *	2002-03-04	2002-03-04	Astrazeneca Ab	Novel Formulation
US7601688B2 (en)	2002-06-13	2009-10-13	Biocon Limited	Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
EP2626368B1 (en)	2004-07-19	2016-12-21	Biocon Limited	Insulin-oligomer conjugates, formulations and uses thereof
US20090047347A1 (en) *	2005-07-29	2009-02-19	Aegis Therapeutics, Inc.	Compositions for Drug Administration
US9895444B2 (en)	2004-08-25	2018-02-20	Aegis Therapeutics, Llc	Compositions for drug administration
EP2457580A1 (en) *	2004-08-25	2012-05-30	The UAB Research Foundation	Absorption enhancers for drug administration
US8268791B2 (en) *	2004-08-25	2012-09-18	Aegis Therapeutics, Llc.	Alkylglycoside compositions for drug administration
US20060046962A1 (en) *	2004-08-25	2006-03-02	Aegis Therapeutics Llc	Absorption enhancers for drug administration
US20140162965A1 (en)	2004-08-25	2014-06-12	Aegis Therapeutics, Inc.	Compositions for oral drug administration
US8226949B2 (en)	2006-06-23	2012-07-24	Aegis Therapeutics Llc	Stabilizing alkylglycoside compositions and methods thereof
CA2702892C (en)	2007-10-16	2017-02-28	Biocon Limited	An orally administerable solid pharmaceutical composition and a process thereof
AU2009228093B2 (en)	2008-03-28	2014-08-07	Neurelis, Inc.	Administration of benzodiazepine compositions
CN101618023B (zh) *	2008-06-30	2011-11-30	江苏先声药物研究有限公司	一种制备微粉化蛋白的方法
US8440631B2 (en)	2008-12-22	2013-05-14	Aegis Therapeutics, Llc	Compositions for drug administration
JP2013527843A (ja)	2010-04-20	2013-07-04	オクタファルマ・アーゲー	医薬タンパク質の新規な安定化剤
PT3415139T (pt)	2011-06-14	2022-06-20	Neurelis Inc	Administração de benzodiazepina
US9480966B2 (en) *	2012-04-30	2016-11-01	General Electric Company	Substrates and methods for collection, stabilization and elution of biomolecules
AU2015235211B2 (en) *	2014-03-25	2020-01-30	Matsutani Chemical Industry Co., Ltd.	Malaria transmission prevention agent having rare sugar as effective component thereof and malarial parasite growth regulating agent
KR20170039660A (ko) *	2014-06-30	2017-04-11	테이트 앤드 라일 인그리디언츠 어메리카즈 엘엘씨	소모품을 위한 코팅 조성물
CN107106641B (zh)	2014-10-31	2021-12-21	葛兰素史密斯克莱知识产权发展有限公司	粉末制剂
ES2912965T3 (es)	2015-09-09	2022-05-30	Drawbridge Health Inc	Dispositivos para la recopilación, estabilización y conservación de muestras
WO2019157099A1 (en)	2018-02-06	2019-08-15	Aegis Therapeutics, Llc	Intranasal epinephrine formulations and methods for the treatment of disease
CN117327132B (zh) *	2023-10-08	2025-08-08	新疆医科大学	刺糖松三糖及其提取工艺和应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
BE556587A (xx) *	1957-01-31	1957-04-11
GB1144905A (en) *	1965-03-25	1969-03-12	Fisons Pharmaceuticals Ltd	Substituted bis-(2-carboxy-chromonyl-oxy) derivatives and preparation and pharmaceutical compositions thereof
DE2750090A1 (de) *	1976-11-19	1978-06-01	Sandoz Ag	Neue verabreichungsformen fuer organische verbindungen
SE7812207L (sv) *	1977-12-01	1979-06-02	Welsh Nat School Med	Apparat, forfarande och framstellda produkter for anvendning vid administration av antihistaminer
JPS6034925B2 (ja) *	1979-07-31	1985-08-12	帝人株式会社	持続性鼻腔用製剤およびその製造法
JPS59163313A (ja) *	1983-03-09	1984-09-14	Teijin Ltd	経鼻投与用ペプチドホルモン類組成物
DE3326089A1 (de) *	1983-07-20	1985-02-07	Gödecke AG, 1000 Berlin	Zur inhalation bestimmte darreichungsform von calcium-antagonisten
JPS61267528A (ja) *	1984-11-26	1986-11-27	Yamanouchi Pharmaceut Co Ltd	吸収促進剤を含有するカルシトニン経鼻剤
DE3686025T2 (de) *	1985-05-22	1993-01-07	Liposome Technology Inc	Verfahren und system zum einatmen von liposomen.
DE3532074A1 (de) *	1985-09-09	1987-03-12	Berlin Chemie Veb	Resorptionsvermittler fuer biologisch aktive peptide
IT1204826B (it) *	1986-03-04	1989-03-10	Chiesi Farma Spa	Composizioni farmaceutiche per inalazione
NZ222907A (en) *	1986-12-16	1990-08-28	Novo Industri As	Preparation for intranasal administration containing a phospholipid absorption enhancing system
US5179079A (en) *	1986-12-16	1993-01-12	Novo Nordisk A/S	Nasal formulation and intranasal administration therewith
SU1672627A1 (ru) *	1988-06-06	1995-11-10	Институт технической теплофизики АН УССР	Способ получения порошка ампиокса натрия
EP0360340A1 (en) *	1988-09-19	1990-03-28	Akzo N.V.	Composition for nasal administration containing a peptide
JPH02104531A (ja) *	1988-10-14	1990-04-17	Toyo Jozo Co Ltd	経鼻投与用生理活性ペプチド組成物
US5011678A (en) *	1989-02-01	1991-04-30	California Biotechnology Inc.	Composition and method for administration of pharmaceutically active substances
US5176132A (en) *	1989-05-31	1993-01-05	Fisons Plc	Medicament inhalation device and formulation
JP2642486B2 (ja) *	1989-08-04	1997-08-20	田辺製薬株式会社	難溶性薬物の超微粒子化法
JPH05963A (ja) *	1990-04-13	1993-01-08	Toray Ind Inc	ポリペプチド類組成物
GB9010742D0 (en) *	1990-05-14	1990-07-04	Quadrant Bioresources Ltd	Stabilization of biological macromolecular substances
NZ241954A (en) *	1991-03-15	1994-01-26	Amgen Inc	Compositions of g-csf for pulmonary administration.
CA2127877A1 (en) *	1992-01-21	1993-07-22	Robert M. Platz	Improved process for preparing micronized polypeptide drugs
ES2179831T3 (es) *	1992-09-29	2003-02-01	Inhale Therapeutic Syst	Liberacion en los pulmones de fragmentos activos de hormona paratiroidiana.
TW402506B (en) *	1993-06-24	2000-08-21	Astra Ab	Therapeutic preparation for inhalation
US5506203C1 (en) *	1993-06-24	2001-02-06	Astra Ab	Systemic administration of a therapeutic preparation
IS1796B (is) *	1993-06-24	2001-12-31	Ab Astra	Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband

1994
- 1994-12-22 SE SE9404468A patent/SE9404468D0/xx unknown
1995
- 1995-12-18 ZA ZA9510753A patent/ZA9510753B/xx unknown
- 1995-12-19 EP EP01130870A patent/EP1224929B1/en not_active Expired - Lifetime
- 1995-12-19 TW TW084113557A patent/TW474823B/zh not_active IP Right Cessation
- 1995-12-19 ES ES01130870T patent/ES2222306T3/es not_active Expired - Lifetime
- 1995-12-19 PL PL95320751A patent/PL183944B1/pl not_active IP Right Cessation
- 1995-12-19 PT PT01130870T patent/PT1224929E/pt unknown
- 1995-12-19 CZ CZ19971946A patent/CZ288487B6/cs not_active IP Right Cessation
- 1995-12-19 ES ES95942342T patent/ES2177674T3/es not_active Expired - Lifetime
- 1995-12-19 SK SK812-97A patent/SK283147B6/sk unknown
- 1995-12-19 DE DE69527542T patent/DE69527542T2/de not_active Expired - Fee Related
- 1995-12-19 CN CN95196965A patent/CN1080114C/zh not_active Expired - Fee Related
- 1995-12-19 NZ NZ298168A patent/NZ298168A/en unknown
- 1995-12-19 HU HU9800493A patent/HU217975B/hu not_active IP Right Cessation
- 1995-12-19 MY MYPI95003942A patent/MY114211A/en unknown
- 1995-12-19 KR KR1019970704254A patent/KR100391873B1/ko not_active Expired - Fee Related
- 1995-12-19 PT PT95942342T patent/PT799030E/pt unknown
- 1995-12-19 EE EE9700135A patent/EE03381B1/xx not_active IP Right Cessation
- 1995-12-19 BR BR9510422A patent/BR9510422A/pt not_active Application Discontinuation
- 1995-12-19 WO PCT/SE1995/001541 patent/WO1996019207A1/en not_active Ceased
- 1995-12-19 DE DE69533294T patent/DE69533294T2/de not_active Expired - Fee Related
- 1995-12-19 AU AU43592/96A patent/AU702898B2/en not_active Ceased
- 1995-12-19 RU RU97112496A patent/RU2144819C1/ru not_active IP Right Cessation
- 1995-12-19 AT AT95942342T patent/ATE220900T1/de not_active IP Right Cessation
- 1995-12-19 AT AT01130870T patent/ATE271382T1/de not_active IP Right Cessation
- 1995-12-19 UA UA97073876A patent/UA44757C2/uk unknown
- 1995-12-19 FI FI972654A patent/FI972654A7/fi unknown
- 1995-12-19 US US08/617,753 patent/US6004574A/en not_active Expired - Fee Related
- 1995-12-19 IL IL11645995A patent/IL116459A/en not_active IP Right Cessation
- 1995-12-19 CA CA002206803A patent/CA2206803A1/en not_active Abandoned
- 1995-12-19 DK DK95942342T patent/DK0799030T3/da active
- 1995-12-19 EP EP95942342A patent/EP0799030B1/en not_active Expired - Lifetime
- 1995-12-19 DK DK01130870T patent/DK1224929T3/da active
- 1995-12-19 JP JP8519731A patent/JPH10510828A/ja active Pending
- 1995-12-21 AR ARP950100706A patent/AR002261A1/es active IP Right Grant
- 1995-12-21 TR TR95/01632A patent/TR199501632A1/xx unknown
- 1995-12-30 SA SA95160484A patent/SA95160484B1/ar unknown
1997
- 1997-06-03 IS IS4495A patent/IS1848B/is unknown
- 1997-06-10 NO NO19972660A patent/NO315966B1/no unknown

Also Published As

Publication number	Publication date
NO315966B1 (no)	2003-11-24
IL116459A (en)	2002-11-10
IL116459A0 (en)	1996-03-31
KR100391873B1 (ko)	2003-10-17
NZ298168A (en)	1999-08-30
ATE271382T1 (de)	2004-08-15
DE69533294T2 (de)	2005-05-19
UA44757C2 (uk)	2002-03-15
RU2144819C1 (ru)	2000-01-27
DK1224929T3 (da)	2004-10-04
SK283147B6 (sk)	2003-03-04
WO1996019207A1 (en)	1996-06-27
AU4359296A (en)	1996-07-10
EP1224929B1 (en)	2004-07-21
HU217975B (hu)	2000-05-28
ES2222306T3 (es)	2005-02-01
CN1080114C (zh)	2002-03-06
ATE220900T1 (de)	2002-08-15
MX9704551A (es)	1997-10-31
US6004574A (en)	1999-12-21
DE69527542D1 (de)	2002-08-29
ES2177674T3 (es)	2002-12-16
AR002261A1 (es)	1998-03-11
PL183944B1 (pl)	2002-08-30
CZ288487B6 (en)	2001-06-13
IS4495A (is)	1997-06-03
EP0799030B1 (en)	2002-07-24
TR199501632A1 (tr)	1997-03-21
DE69533294D1 (de)	2004-08-26
JPH10510828A (ja)	1998-10-20
FI972654A0 (fi)	1997-06-19
SA95160484B1 (ar)	2005-10-01
SE9404468D0 (sv)	1994-12-22
CA2206803A1 (en)	1996-06-27
MY114211A (en)	2002-08-30
DK0799030T3 (da)	2002-09-16
PL320751A1 (en)	1997-10-27
HUT77648A (hu)	1998-07-28
HK1003619A1 (en)	1998-11-06
FI972654L (fi)	1997-06-19
EP1224929A2 (en)	2002-07-24
NO972660L (no)	1997-06-10
EE9700135A (et)	1997-12-15
EP1224929A3 (en)	2002-12-18
AU702898B2 (en)	1999-03-11
ZA9510753B (en)	1996-06-24
PT799030E (pt)	2002-11-29
BR9510422A (pt)	1998-07-07
EP0799030A1 (en)	1997-10-08
NO972660D0 (no)	1997-06-10
IS1848B (is)	2003-02-07
DE69527542T2 (de)	2003-01-30
PT1224929E (pt)	2004-10-29
FI972654A7 (fi)	1997-06-19
SK81297A3 (en)	1997-11-05
CN1171049A (zh)	1998-01-21
CZ194697A3 (en)	1997-10-15
TW474823B (en)	2002-02-01

Publication	Publication Date	Title
EE03381B1 (et)	2001-04-16	Pulbrilised ravimvormid, mis sisaldavad lahjendajana melesitoosi
DE69419519D1 (de)	1999-08-19	Riechstoffe formulierungen
EP0674898A3 (en)	1997-06-04	Shampoo composition.
PT946100E (pt)	2003-11-28	Composicoes herbicidas contendo n-¬(4,6-dimetoxipirimidin-2-il)aminocarbonil\|-5-metilsulfonamidometil-2-alcoxicarbonilbenzenossulfonamidas
ID21482A (id)	1999-06-17	Turunan-turunan pirazol yang berguna sebagai herbisida
FI972168L (fi)	1997-05-21	Oraaliset koostumukset, jotka sisältävät ondansetronia
ZA989767B (en)	2000-04-28	Novel compounds.
ZA976777B (en)	1998-02-11	Anthelmintic formulations.
EE200100293A (et)	2002-08-15	Kontrollitud vabanemisega ravivorm, mis sisaldab GnRH-II
ZA200005478B (en)	2001-10-08	Shampoo compositions.
DZ1835A1 (fr)	2002-02-17	Nouvelles formulations.
HU9503194D0 (en)	1995-12-28	Novel sunsscreens, photoprotective cosmetic compositions containing them and uses thereof
DE59900501D1 (de)	2002-01-17	Feste, schnellzerfallende cetirizin-formulierungen
FR2712491B1 (fr)	1996-12-27	Compositions antisudorales.
ZA932689B (en)	1994-10-16	Disinfectant compositions.
ZA9710272B (en)	1998-06-10	Pharmaceutical compositions comprising diaryl-cyclomethylenpyrazole compounds.
HU9603204D0 (en)	1997-01-28	Substituted 3-phenylpyrazoles for use as herbicides
EP0664115A3 (en)	1996-11-06	Shampoo composition.
EP0584655A3 (en)	1994-06-15	3-aryl-triazine-2,4-diones as herbicides
ZA9811503B (en)	2000-06-15	Novel compounds.
ZA9811758B (en)	2000-06-22	Novel compounds.
TR199700147A2 (tr)	1997-09-21	Mikrop öldürücü terkip.
GB9806312D0 (en)	1998-05-20	Novel formulations
GB9422682D0 (en)	1995-01-04	Herbicidal methods, compositions and compounds
EP0866709A4 (en)	2002-07-17	1,2,4-benzotriazine oxides formulations

Legal Events

Date	Code	Title	Description
2003-02-17	KB4A	Valid patent at the end of a year	Effective date: 20021231
2004-02-16	KB4A	Valid patent at the end of a year	Effective date: 20031231
2005-02-15	KB4A	Valid patent at the end of a year	Effective date: 20041231
2006-02-15	KB4A	Valid patent at the end of a year	Effective date: 20051231
2007-02-15	KB4A	Valid patent at the end of a year	Effective date: 20061231
2008-02-15	KB4A	Valid patent at the end of a year	Effective date: 20071231
2008-08-15	MM4A	Lapsed by not paying the annual fees	Effective date: 20071219